Genesis Wealth Advisors’s Biogen BIIB Stock Holding History

Genesis Wealth Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$7.27K	Buy	+18	New	+$7.22K	0.01%	374

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Genesis Wealth Advisors's BIIB Position: Q2 2015 in Review

Genesis Wealth Advisors opened a new position in Biogen (BIIB) in Q2 2015: 18 shares worth $7.27K. The stake represents 0.01% of the portfolio and ranks #374 among its holdings.

974 funds tracked by Wall St. Rank hold BIIB as of Q2 2015.

Genesis Wealth Advisors held 18 shares of Biogen worth $7.27K as of Q2 2015.
Biogen was a new Genesis Wealth Advisors position in Q2 2015.
Biogen made up 0.01% of Genesis Wealth Advisors's portfolio in Q2 2015, its #374 holding.
974 funds tracked by Wall St. Rank held Biogen as of Q2 2015.

Based on Genesis Wealth Advisors's 13F filing for Q2 2015, filed 24 Aug 2015.